Frontiers in Oncology (Dec 2022)

Simulation of dosimetric consequences of intrafraction variation of tumor drift in lung cancer stereotactic body radiotherapy

  • Bin Han,
  • Bian Wu,
  • Fala Hu,
  • Yangguang Ma,
  • Haiyang Wang,
  • Xinwei Han,
  • Gang Liu,
  • Yuexin Guo

DOI
https://doi.org/10.3389/fonc.2022.1010411
Journal volume & issue
Vol. 12

Abstract

Read online

ObjectiveThe purpose of this study was to investigate the target dose discrepancy caused by intrafraction variation during stereotactic body radiotherapy (SBRT) for lung cancer.MethodsIntensity-modulated radiation therapy (IMRT) plans were designed based on average computed tomography (AVG CT) utilizing the planning target volume (PTV) surrounding the 65% and 85% prescription isodoses in both phantom and patient cases. Variation was simulated by shifting the nominal plan isocenter along six directions from 0.5 mm to 4.5 mm with a 1-mm step size to produce a series of perturbed plans. The dose discrepancy between the initial plan and the perturbed plans was calculated as the percentage of the initial plan. Dose indices, including ΔD99 for internal target volume (ITV) and gross tumor volume (GTV), were adopted as endpoint samples. The mean dose discrepancy was calculated under the 3-dimensional space distribution.ResultsWe found that motion can lead to serious dose degradation of the target and ITV in lung SBRT, especially during SBRT with PTV surrounding the lower isodose line. Lower isodose line may lead to larger dose discrepancy, while make steeper dose fall-off gradient. This phenomenon was compromised when 3-dimensional space distribution was considered.DiscussionThis result may provide a prospective reference for target dose degradation due to motion during lung SBRT treatment.

Keywords